Purchase Order 75H71024P01438
- Not listed
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of COVID-19 test kits to the Department of Health and Human Services Indian Health Service. The firm fixed-price contract has a potential value of $173,730.00 and is set to be completed by April 5, 2023. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Indian Health...
- This federal contract award is for the delivery of COVID-19 testing kits to the Department of Health and Human Services Indian Health Service. The prime contractor is Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract has a potential value of $106,500.00 and is a firm fixed price delivery order. Cepheid, a subsidiary of Danaher Corporation, has provided a range of diagnostic testing products and services to various...
- This federal contract award is for Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4PLEX+ COVID-19 TESTING KITS to the Indian Health Service (IHS). The award, valued at $402,084.00, is a firm fixed-price delivery order placed under an existing Indefinite Delivery Contract. The contract has no set-aside designation. Cepheid has previously received various federal contract awards and grants, including Blanket Purchase Agreements with the Department of...
- This is a firm fixed-price purchase order contract awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $710,600.00, is for the provision of COVID-19 test kits from Cepheid on an "as needed" basis, with a period of performance through December 31, 2023. The contract does not have a set-aside designation. Cepheid is a...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, worth up to $170,000.00, was awarded by the Department of Health and Human Services Indian Health Service. The contract is a delivery order and is a firm fixed-price contract type. The contract is not set aside. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms...
- The Department of Health and Human Services Indian Health Service awarded a $367,200.00 firm fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4-PLEX COVID-19 TESTING KITS. The contract has a completion date of December 27, 2021 and was awarded on December 28, 2020. This award was not set aside. Cepheid is the prime contractor and no major subcontractors are mentioned. The contract supports the Indian Health...
- This federal contract award was issued by the Indian Health Service, a civilian agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the delivery of 100 COVID-19 4-plex test kits and 200 SARS COVID-19 test kits from Cepheid. The contract is a firm fixed-price delivery order with a ceiling value of $71,850.00 and a completion date of September 30, 2025. This contract is not designated as a set-aside. Cepheid is the prime contractor and does not have...
- This federal contract award, valued at $74,000.00, was issued by the Indian Health Service (IHS) to the prime contractor Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the delivery of COVID-19 test kits to the Federal Covd-19 Response Coordination Hub (FCRHC). The contract is a firm fixed-price purchase order with a completion date of September 15, 2026. Cepheid is an experienced federal contractor, holding several...
- This federal contract award was issued by the Department of Health and Human Services Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The $408,000.00 Delivery Order is for the provision of COVID-19 testing kits to support the Indian Health Service's diagnostic programs. The award does not utilize any set-aside designation. Cepheid, a subsidiary of the Danaher Corporation, has an extensive history of supplying...
- This federal contract award to Cepheid, a for-profit manufacturer of diagnostic solutions, is for the purchase of analyzers, related equipment, supplies, and services to support COVID-19 testing and patient care for the Department of Health and Human Services (HHS) Indian Health Service. The $297,270.00 fixed-price delivery order does not utilize a set-aside designation. As the prime contractor, Cepheid will provide reagents, test kits, instruments, and testing platforms to the Indian Health...
This federal contract award is for the procurement of COVID-19 testing kits by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $243,250.00, was awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions including infectious disease tests. The contract is a firm fixed-price purchase order with an ultimate completion date of August 31, 2025. Cepheid is the prime contractor and there is no set-aside designation for this award. The place of performance is Sunnyvale, CA. Cepheid has received numerous other federal contracts and grants, including awards from the Department of Veterans Affairs, Defense Logistics Agency, and Department of Health and Human Services to provide diagnostic testing equipment, reagents, and associated services. The company has also participated as a subrecipient on federal grant awards, collaborating with university partners on research projects.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $243.3k | 9/10/24 |